Skip to content

Insider · CIK 0001252004

Robert S Epstein

director

Files at ILMN (ILLUMINA, INC.), VCYT (VERACYTE, INC.), FATE (FATE THERAPEUTICS INC). First filing Nov 14, 2024, latest Oct 3, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $1.3M sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

VCYT: VERACYTE, INC.

VCYTOct 9, 2026 · close 45.23

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
20Weak
VCYTsell 210b5-1
VERACYTE, INC.
$753k
21,473 shares
-26%+57% from low-22% from high
24Weak
VCYTsell 310b5-1
VERACYTE, INC.
$575k
15,000 shares
-25%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Oct 1, 2025VCYT
VERACYTE, INC.
MOption exercise
Common Stock10b5-1
+10,000$7.94$79k83,919Oct 3, 2025
Oct 1, 2025VCYT
VERACYTE, INC.
SOpen-market sale
Common Stock10b5-1
-21,473$35.08$753k62,446Oct 3, 2025
Oct 1, 2025VCYT
VERACYTE, INC.
MOption exercise
Stock Option (right to buy)derivative10b5-1
-10,000$0.00$00Oct 3, 2025
Jun 18, 2025VCYT
VERACYTE, INC.
AGrant or award
Common Stock
+9,321$0.00$073,919Jun 23, 2025
May 29, 2025FATE
FATE THERAPEUTICS INC
AGrant or award
Stock Option (Right to Buy)derivative
+55,000$0.00$055,000May 30, 2025
May 21, 2025ILMN
ILLUMINA, INC.
AGrant or award
Common Stock
+3,780$0.00$022,139May 23, 2025
Jan 6, 2025VCYT
VERACYTE, INC.
MOption exercise
Common Stock
+20,000$8.04$161k64,598Jan 8, 2025
Jan 6, 2025VCYT
VERACYTE, INC.
MOption exercise
Stock Option (right to buy)derivative
-20,000$0.00$00Jan 8, 2025
Nov 12, 2024VCYT
VERACYTE, INC.
MOption exercise
Common Stock10b5-1
+15,000$8.04$121k59,598Nov 14, 2024
Nov 12, 2024VCYT
VERACYTE, INC.
SOpen-market sale
Common Stock10b5-1
-15,000$38.32$575k44,598Nov 14, 2024
Nov 12, 2024VCYT
VERACYTE, INC.
MOption exercise
Stock Option (right to buy)derivative10b5-1
-15,000$0.00$020,000Nov 14, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Robert S Epstein: insider trades and track record | InsiderTell